Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 2281 AL 2295

Novel Heterocyclic Piperazine Amide Derivatives as Alpha-synuclein PET Ligands for Diagnosis of Parkinson's Disease

Li Y, Liang SH.

ACS Med Chem Lett. 2025 Jan 6;16(2):184-185. doi: 10.1021/acsmedchemlett.4c00606. eCollection 2025 Feb 13.

Moving to a non-dopaminergic approach for the treatment of OFF fluctuations in Parkinson's disease

Isaacson SH, Jenner P.

Clin Park Relat Disord. 2025 Jan 27;12:100303. doi: 10.1016/j.prdoa.2025.100303. eCollection 2025.

The possible effects of chili peppers on ADHD in relation to the gut microbiota

Li Y, Feng J, Ding G, Deng L, He Y, Zhang Q, Wang J, Chen X.

Front Nutr. 2025 Feb 4;12:1551650. doi: 10.3389/fnut.2025.1551650. eCollection 2025.

Opicapone to Treat Early Wearing-off in Parkinson's Disease Patients: The European Experience

Ferreira JJ, Poewe W, Rocha JF, Rascol O.

Mov Disord Clin Pract. 2025 May;12(5):713-714. doi: 10.1002/mdc3.70016. Epub 2025 Feb 19.

Pervasive role of pruritus in impaired quality of life in patients with primary biliary cholangitis: Data from the GLIMMER study

Smith HT, Das S, Fettiplace J, von Maltzahn R, Troke PJF, McLaughlin MM, Jones DE, Kremer AE.

Hepatol Commun. 2025 Feb 19;9(3):e0635. doi: 10.1097/HC9.0000000000000635. eCollection 2025 Mar 1.

iPSC-based cell replacement therapy: from basic research to clinical application

Takahashi J.

Cytotherapy. 2025 Jul;27(7):835-842. doi: 10.1016/j.jcyt.2025.01.015. Epub 2025 Feb 1.

miRNAs in neurodegenerative diseases: from target screening to precision therapy

Liao D, Zhang Y, Li S, Tang H, Bai X.

Neurol Sci. 2025 Jun;46(6):2393-2399. doi: 10.1007/s10072-025-08051-8. Epub 2025 Feb 19.

Hypokinetic-rigid gait disorders with balance impairment - A walk through clinical and pathophysiological definitions

Jalles C, Guerreiro D, Pona-Ferreira F, Simões RM, Reimão S, Ferreira JJ.

Parkinsonism Relat Disord. 2025 Apr;133:107339. doi: 10.1016/j.parkreldis.2025.107339. Epub 2025 Feb 14.

Prasinezumab slows motor progression in Parkinsons disease: beyond the clinical data

Xiao B, Tan EK.

NPJ Parkinsons Dis. 2025 Feb 19;11(1):31. doi: 10.1038/s41531-025-00886-4.

Complex striate-frontal projection and specific frontal gyrus dysfunctions concern with the delusional misidentification syndrome: A case report and literature review

Matsuzono K, Onuki Y, Otsuka K, Hiki H, Anan Y, Mashiko T, Koide R, Kunii N, Kawai K, Fujimoto S.

Sci Prog. 2025 Jan-Mar;108(1):368504251322083. doi: 10.1177/00368504251322083.

Estimation of and clinical consensus on the meaningful motor progression threshold on MDS-UPDRS Part III

Trundell D, Davies EW, Barrett L, Zanigni S, Shariati N, Rogers R, Monnet A, Moore E, Pross N, Pagano G, Cano S, Nikolcheva T.

J Parkinsons Dis. 2025 Feb;15(1):97-110. doi: 10.1177/1877718X241302337. Epub 2025 Jan 14.

Improving recruitment and retention of people with Parkinson's disease to clinical studies: A scoping review

Petty R, Agarwal V, Allison J, Bartolomeu-Pires S, Bartlett M, Boey T, Croucher R, Collins H, Collins S, Davies E, Duffen J, Ellis-Doyle R, Gonzalez-Robles C, Inches J, Mills G, Wonnacott S, Foltynie T, Allgar V, Thompson T, Carroll CB, Mullin S, Louise-Zeissler M; EJS ACT-PD Consortium.

J Parkinsons Dis. 2025 Feb;15(1):6-18. doi: 10.1177/1877718X241291986. Epub 2025 Jan 14.

Therapeutic modalities of deferiprone in Parkinson's disease: SKY and EMBARK studies

Devos D, Rascol O, Meissner WG, Foubert-Samier A, Lewis S, Tranchant C, Anheim M, Maltête D, Remy P, Eggert K, Pape H, Geny C, Couratier P, Carroll C, Sheridan R, Burn D, Pavese N, Raw J, Berg D, Suchowersky O, Kalia LV, Evans A, Drapier S, Danaila T, Schnitzler A, Corvol JC, Defer G, Temin NT, Fradette C, Tricta F, Moreau C; a Parkinson's disease study group.

J Parkinsons Dis. 2025 Feb;15(1):72-86. doi: 10.1177/1877718X241300295. Epub 2024 Dec 27.

Pointing in the right direction: Greater motor improvements with directional versus circular subthalamic nucleus deep brain stimulation for Parkinson's disease

Hurt CP, Kuhman DJ, Moll A, Guthrie BL, Olson JW, Nakhmani A, Wade M, Brinkerhoff SA, Holland MT, Walker HC.

J Parkinsons Dis. 2025 Feb;15(1):202-213. doi: 10.1177/1877718X241301071. Epub 2024 Dec 27.

Addressing the need for standardization of symptomatic medication documentation in Parkinson's disease clinical research: A call to action

Spott M, Javidnia M, Pedata A, Müller M, Carrillo L, Simuni T, Pagano G, Kwok K, Romero K, Stephenson D.

J Parkinsons Dis. 2025 Feb;15(1):227-235. doi: 10.1177/1877718X241305711. Epub 2025 Jan 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias